Ariad Pharmaceuticals Inc. (ARIA)


Ariad Pharmaceuticals Inc. discovers and develops medicines to treat cancer by regulating cell signaling with small molecules. The company is developing a comprehensive approach to the treatment of cancer and is primarily focused on a series of product candidates for targeted indications.

View SEC Filings from ARIA instead.
Filers who had this stock in their top 10: 7
13F Filers holding this stock: 201
Aggregate shares on 09/30/2016: 165,371,446
Aggregate shares on 06/30/2016: 138,751,168
Percent change: 19.19%
Funds creating new positions: 49
Funds Adding to an existing position: 62
Funds closing out their position: 28
Funds reducing their position: 62
View recent insider trading info

13F Filers holding this stock

Quarter 1: Refresh

Changes in Holdings:

*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Schedule 13D and 13G filings submitted since 09/30/2016

Subscription required

Click here to report any possible errors with this stock listing.

Elevate your investments

or Learn more